Ajax-Loading

AstraZeneca PLC - Price To Cashflow Ratio

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Price-To-Cashflow-Ratio" stands at 15.22 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of AstraZeneca PLC's third quarter, the item "Price To Cashflow Ratio" stands at 15.22. This represents a decrease of -7.21 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -27.97 percent compared to the value the year prior.
The 1 year change in percent is -27.97.
The 3 year change in percent is -16.81.

The Serie's long term average value is 20.15. It's latest available value, on 09/30/2025, is 24.47 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -43.19%.

Price To Cashflow Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Cashflow Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Cashflow Ratio486,508,953,600.00
LogoAbbVie Inc - Price To Cashflow Ratio399,570,305,024.00
LogoRoche Holding AG - Price To Cashflow Ratio317,433,206,677.55
LogoNovartis AG - Price To Cashflow Ratio255,096,620,580.91